February 10, 2020 11:03 AM ESTUpdated 11:31 AM

Are priority review voucher programs stimulating drug development? The data suggest not really, finds GAO report

What is the impact of the three priority review voucher programs (PRV) on drug development? Not much, according to

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Are pri­or­i­ty re­view vouch­er pro­grams stim­u­lat­ing drug de­vel­op­ment? The da­ta sug­gest not re­al­ly, finds GAO re­port